Market Overview

Trade GMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
5/24/19DowngradesOutperformMarket Perform
2/28/19UpgradesNeutralBuy
1/02/19DowngradesOverweightEqual-Weight49.0
Show more Loading articles...

Earnings View Earnings

Q2 2019 EST Actual Surprise
EPS: 0.410 0.410 0.0000
Rev: 184.93M 194.54M 9.61M
Q3 2019 EST Actual Surprise
EPS: Expected
2019-11-07
Rev:
Fastest Market News Application
You'll Hear It First On Pro

Company Profile